GEREMY (EU project)

GEREMY (EU project)

Onderzoeksdiensten

Gene Therapy for treatment of rare inherited Arrhythmogenic CardioMyopathy

Over ons

The GEREMY project is funded by the European Health & Digital Executive Agency and aims to deliver the first cardiac gene therapy (GT) for treatment of rare inherited forms of arrhythmogenic cardiomyopathy (ACM), such as PLN- and PKP2-mutation induced ACM. These will serve as models for other inherited heart diseases and contribute directly to the portfolio of treatments for rare cardiac diseases

Branche
Onderzoeksdiensten
Bedrijfsgrootte
11 - 50 medewerkers
Hoofdkantoor
Utrecht
Opgericht
2023

Updates

Gerelateerde pagina’s

Vergelijkbare pagina’s